{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T08:27:53Z","timestamp":1793953673819,"version":"4.8.0"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T00:00:00Z","timestamp":1774656000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000266","name":"Engineering and Physical Sciences Research Council","doi-asserted-by":"publisher","award":["EP\/X031276\/1"],"award-info":[{"award-number":["EP\/X031276\/1"]}],"id":[{"id":"10.13039\/501100000266","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["224029\/Z\/21\/Z"],"award-info":[{"award-number":["224029\/Z\/21\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"UK Research and Innovation Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013342","name":"National Institute for Health Research Imperial Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013342","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","award":["ACF-2023-18-006"],"award-info":[{"award-number":["ACF-2023-18-006"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.ijid.2026.108660","type":"journal-article","created":{"date-parts":[[2026,3,29]],"date-time":"2026-03-29T23:26:27Z","timestamp":1774826787000},"page":"108660","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Ciprofloxacin prophylaxis in allogeneic haematopoietic cell transplantation reduces bacteraemia but increases antimicrobial resistance without improving patient outcomes"],"prefix":"10.1016","volume":"167","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8008-4835","authenticated-orcid":false,"given":"Ioannis","family":"Baltas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jure","family":"Hederih","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nora","family":"Kvam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Kavallieros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giannis","family":"Konstantinou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eirini","family":"Koutoumanou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malick M.","family":"Gibani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Gilchrist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis","family":"Grandjean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frances","family":"Davies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate","family":"Stringaris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanya","family":"Gant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Ji\u0159\u00ed Pavl\u016f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.ijid.2026.108660_bib0001","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1038\/s41409-022-01674-x","article-title":"Reduced intensity versus non-myeloablative conditioning regimen for haploidentical transplantation and post-transplantation cyclophosphamide in complete remission acute myeloid leukemia: a study from the ALWP of the EBMT","volume":"57","author":"Devillier","year":"2022","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"10.1016\/j.ijid.2026.108660_bib0002","doi-asserted-by":"crossref","DOI":"10.1093\/jacamr\/dlae010","article-title":"The effect of ciprofloxacin prophylaxis during haematopoietic cell transplantation on infection episodes, exposure to treatment antimicrobials and antimicrobial resistance: a single-centre retrospective cohort study","volume":"6","author":"Baltas","year":"2024","journal-title":"JAC Antimicrob Resist"},{"issue":"2","key":"10.1016\/j.ijid.2026.108660_bib0003","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.14172","article-title":"Infectious complications in allogeneic hematopoietic cell transplant recipients: review of transplant-related risk factors and current state of prophylaxis","volume":"35","author":"Akhmedov","year":"2021","journal-title":"Clin Transplant"},{"key":"10.1016\/j.ijid.2026.108660_bib0004","article-title":"Antibiotic prophylaxis for bacterial infections in afebrile neutropenic patients following chemotherapy","volume":"1","author":"Gafter-Gvili","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"issue":"9","key":"10.1016\/j.ijid.2026.108660_bib0005","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0105706","article-title":"Complete suppression of the gut microbiome prevents acute graft-versus-host disease following allogeneic bone marrow transplantation","volume":"9","author":"Vossen","year":"2014","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.ijid.2026.108660_bib0006","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1111\/tid.12298","article-title":"Changing microbial epidemiology in hematopoietic stem cell transplant recipients: increasing resistance over a 9-year period","volume":"16","author":"Macesic","year":"2014","journal-title":"Transpl Infect Dis"},{"issue":"2","key":"10.1016\/j.ijid.2026.108660_bib0007","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1093\/jac\/dkae440","article-title":"Trends in fluoroquinolone prescribing in UK primary and secondary care between 2019 and 2023","volume":"80","author":"Hamilton","year":"2025","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijid.2026.108660_bib0008","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofaf105","article-title":"Levofloxacin to prevent bacterial infection in patients with acute myeloid leukemia treated by venetoclax and azacitidine: a Toulouse-Bordeaux DATAML registry study","volume":"12","author":"Brousse","year":"2025","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.ijid.2026.108660_bib0009","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijid.2024.107172","article-title":"Ciprofloxacin versus levofloxacin prophylaxis in hematopoietic stem cell transplantation: a randomized trial","volume":"147","author":"Farhan","year":"2024","journal-title":"Int J Infect Dis"},{"issue":"6","key":"10.1016\/j.ijid.2026.108660_bib0010","doi-asserted-by":"crossref","DOI":"10.1099\/jmm.0.001847","article-title":"Ciprofloxacin prophylaxis during haematopoietic cell transplantation: a role for use in patients with germ cell tumours?","volume":"73","author":"Kavallieros","year":"2024","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.ijid.2026.108660_bib0011","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofae707","article-title":"Levofloxacin prophylaxis in pediatric and young adult allogeneic hematopoietic stem cell transplantation recipients does not prevent infective complications and infections-related deaths","volume":"12","author":"Leardini","year":"2025","journal-title":"Open Forum Infect Dis"},{"issue":"5","key":"10.1016\/j.ijid.2026.108660_bib0012","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1086\/511640","article-title":"Measurement of adult antibacterial drug use in 130 US hospitals: comparison of defined daily dose and days of therapy","volume":"44","author":"Polk","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2026.108660_bib0013","series-title":"The EBMT Handbook: Hematopoietic Stem Cell Transplantation and Cellular Therapies [Internet]","article-title":"Mohty","author":"Carreras","year":"2019"},{"issue":"12","key":"10.1016\/j.ijid.2026.108660_bib0014","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.3324\/haematol.2013.091025","article-title":"European guidelines for empirical antibacterial therapy for febrile neutropenic patients in the era of growing resistance: summary of the 2011 4th European Conference on Infections in Leukemia","volume":"98","author":"Averbuch","year":"2013","journal-title":"Haematologica"},{"issue":"4","key":"10.1016\/j.ijid.2026.108660_bib0015","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1182\/blood-2004-11-4557","volume":"106","author":"Cahn","year":"2005","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.ijid.2026.108660_bib0016","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/j.cmi.2018.03.030","article-title":"Contaminants in blood cultures: importance, implications, interpretation and prevention","volume":"24","author":"Darg\u00e8re","year":"2018","journal-title":"Clin Microbiol Infect"},{"issue":"6","key":"10.1016\/j.ijid.2026.108660_bib0017","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1093\/cid\/ciz1008","article-title":"Revision and update of the consensus definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium","volume":"71","author":"Donnelly","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.ijid.2026.108660_bib0018","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1093\/cid\/ciab1000","article-title":"Cessation of ciprofloxacin prophylaxis in hemato-oncology patients","volume":"75","author":"Caldwell","year":"2022","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.ijid.2026.108660_bib0019","doi-asserted-by":"crossref","DOI":"10.5812\/amh-130618","article-title":"Efficacy of ciprofloxacin in prevention of sepsis among the patients with chemotherapy-induced neutropenia: a randomized double-blind clinical trial in a university hospital in Tehran, Iran","volume":"20","author":"Asgari","year":"2022","journal-title":"Ann Mil Health Sci Res"},{"issue":"12","key":"10.1016\/j.ijid.2026.108660_bib0020","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1016\/S1470-2045(19)30506-6","article-title":"Levofloxacin prophylaxis in patients with newly diagnosed myeloma (TEAMM): a multicentre, double-blind, placebo-controlled, randomised, phase 3 trial","volume":"20","author":"Drayson","year":"2019","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.ijid.2026.108660_bib0021","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1093\/jac\/dkad355","article-title":"UK clinicians\u2019 attitudes towards the application of molecular diagnostics to guide antibiotic use in ICU patients with pneumonias: a quantitative study","volume":"79","author":"Stewart","year":"2024","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"10.1016\/j.ijid.2026.108660_bib0022","doi-asserted-by":"crossref","DOI":"10.1128\/aac.01156-24","article-title":"Guidelines vs mindlines: a qualitative investigation of how clinicians\u2019 beliefs influence the application of rapid molecular diagnostics in intensive care","volume":"69","author":"Stewart","year":"2025","journal-title":"Antimicrob Agents Chemother"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S120197122600295X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S120197122600295X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T08:03:38Z","timestamp":1793952218000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S120197122600295X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":22,"alternative-id":["S120197122600295X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2026.108660","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ciprofloxacin prophylaxis in allogeneic haematopoietic cell transplantation reduces bacteraemia but increases antimicrobial resistance without improving patient outcomes","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2026.108660","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}],"article-number":"108660"}}